Open research questions in Pain Management and Opioid Use
216 unresolved questions extracted from the limitations and future-work sections of 1,278 Pain Management and Opioid Use papers in our library. Each links back to the study that raised it.
What the literature leaves open
The available evidence is heterogeneous across patient populations, surgical procedures, analgesic techniques, and outcome definitions. No single patient characteristic consistently predicts postoperative pain or opioid requirements.
Individualizing Perioperative Analgesia: Patient-Specific Determinants of Postoperative Pain and Opioid-Related Outcomes · 2026 · DOIThe mismatch between expectations and realities of chronic pain. The lack of recognition of chronic pain as a systems level public health issue. The need to create realistic expectations and reduce the misattribution of system-shaped outcomes to individual failure.
The expectations we build: reframing chronic pain outcomes as a systems level public health issue · 2026 · DOIWhile pain is a known risk factor for cognitive decline, its dyadic effects within couples remain poorly understood.
The influence of pain on the cognitive function of middle-aged and older couples in China · 2026 · DOIThey maintain a well-established role in acute postoperative and cancer-related pain, whereas their use in chronic non-cancer pain remains controversial.
Optimizing Opioid Use in Pain Management: A Comprehensive Review of Clinical Benefits, Risks, and Dependence · 2026 · DOIBACKGROUND: Older people with dementia are frequently prescribed opioids, but little is known about adverse events associated with opioid use in this population.
• An important gap in the literature is the impact of nursing students'own experience of pain on clinical pain management.
Pain knowledge and personal experiences can influence clinical pain management attitudes: a cross-sectional study · 2025 · DOIConclusions: Pharmacological interventions, particularly dexamethasone and lidocaine, remain the cornerstone of pain management in TACE, yet consensus on their optimal use is lacking.
Strategies for Pain Management in Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolisation: A Scoping Review of Current Evidence · 2025 · DOIHowever, post-procedural pain remains a significant challenge due to inconsistent management practices and a lack of standardised protocols.
Strategies for Pain Management in Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolisation: A Scoping Review of Current Evidence · 2025 · DOILittle is known about unintended outcomes of this guideline on analgesic prescribing for older adults with cancer, who commonly require opioids as first-line pain treatment.
The 2016 CDC Opioid Guideline and Analgesic Prescribing Patterns in Older Adults With Cancer · 2025 · DOIEvidence on the quality of life of patients with refractory chronic non-cancer pain (CNCP) using these devices and their long-term outcomes is scarce.
Multidimensional Analysis of Quality of Life in Patients with Chronic Non-Cancer Pain and Short- and Long-Term Intrathecal Analgesic Therapy · 2024 · DOIWe need to first ask how was pain control or relief measured and if the conclusion is warranted based on the assessment strategy.
There is a lack of effective tools to evaluate nurses' pain-management competency. Existing tools may not be specific to surgical nurses or postoperative pain management.
Development and psychometric evaluation of a tool to measure pain-management competency of surgical nurses · 2026 · DOIThere is a lack of comprehensive studies on pain assessment and management in people with dementia. Prior work has shown that pain in people with dementia is often undermanaged.
Observing and treating pain in people living with dementia in long-term care facilities · 2026 · DOIStandardized pain management guidelines and stepwise protocols for pain assessment and management in long-term care facilities may contribute to reducing the underdiagnosis and undertreatment of pain in individuals with dementia. Structured approaches, such as the Sta-op! method support systematic observation and identification of pain-related behaviors. Using this method in combination with the guidelines on pain in people with dementia, such as the Verenso Guideline, may promote increased use of non-pharmacological interventions for pain management (28). To our knowledge, this is the first study to provide an overview of how pain is observed, assessed, and managed in Dutch long-term care facilities. Strengths of this study include mixed-methods sequential explanatory design and the use of in-depth interviews to contextualize survey findings. The nationwide distribution of the survey contributes to the generalizability of the findings. Also, findings like the emphasis on behavioral changes as key indicators of pain in individuals with impaired communication are likely relevant beyond the Dutch context and reflect issues faced in long-term care facilities be several internationally. However, acknowledged. Participants were not asked to specify their longterm care facility, limiting insight into organizational diversity. Therefore, there could be a bias where facilities with solidly embedded pain management programs participated in the study, while facilities with less embedded programs did not. Also, participant were not asked which specific observational pain scales were used in practice. This information could have provided insight into the usability of different instruments. The small restricts number of managers generalizability for these groups. Another is that different subgroups have different roles in the interprofessional team that provides the pain observations and management, but the subgroups were too small to analyze separately. Both survey and interview data may be subject to socially desirable responses, and the study title may have led to overreporting of nonpharmacological intervention use. Self-reported measures of pain are widely considered the gold standard, including in populations with dementia. However, in the present study, specific inquiries regarding the utilization of self-report instruments for pain assessment were not conducted. Consequently, it remains unclear whether self-reports are employed in individuals with dementia, the frequency of their use, or whether individuals are first asked about their pain experience prior to implementing observational assessment tools. Additionally, most participants were female and highly educated, which may limit representativeness.
Observing and treating pain in people living with dementia in long-term care facilities · 2026 · DOIThe study excluded patients without available PCA device logs, - The analysis was limited to patients undergoing specific surgical procedures
Beyond opioid dosage: temporal dynamics of intravenous patient-controlled analgesia use captured by electronic device logs—a post hoc analysis of three randomized controlled trials · 2026 · DOIThe need for a detailed understanding of IV-PCA usage patterns, - The importance of considering temporal dynamics in IV-PCA use
Beyond opioid dosage: temporal dynamics of intravenous patient-controlled analgesia use captured by electronic device logs—a post hoc analysis of three randomized controlled trials · 2026 · DOIThere is a gap between the evidence and clinical implementation of pain management practices. Current pain assessment practices often fail to reflect best evidence.
Optimising pain management in intensive care setting: Insights from a realist evaluation · 2026 · DOIBuilding on previous insights, we propose the following recommendations to optimise pain management for sedated and ventilated patients. Collaborative engagement from all stakeholders may be essential to achieve this goal and improve outcomes across organ- isational levels. Table 2 provides a summary of these recommendations.
Optimising pain management in intensive care setting: Insights from a realist evaluation · 2026 · DOIAccumulated multimorbidity, frailty, and polypharmacy in older adults. Limited oral opioid regimens due to dysphagia, nausea, bowel dysfunction, or rapidly fluctuating symptom intensity. Need for effective rescue strategies for severe opioid-refractory cancer pain.
Subcutaneous patient-controlled analgesia with hydromorphone for the treatment of refractory cancer pain in older hospitalized patients: a retrospective real-world study · 2026 · DOIMissingness remained below 10% for the primary outcome but was higher for selected baseline measures. The study used complete-case analyses rather than multiple imputation due to uncertain missing-at-random assumptions. Delirium was not systematically coded in the source dataset and could not be evaluated.
Subcutaneous patient-controlled analgesia with hydromorphone for the treatment of refractory cancer pain in older hospitalized patients: a retrospective real-world study · 2026 · DOIThe certainty of evidence was evaluated as low for all outcomes, mainly due to population heterogeneity and lack of uniformity in intervention administration. Missing outcome data and selective reporting were sources of uncertainty. The main source of concern related to confounding and participant selection in nonrandomized studies.
Cannabinoids and opioid consumption in cancer pain: a systematic review and meta-analysis · 2026 · DOIThe impact of cannabinoids on opioid consumption in cancer patients remains uncertain. There is a need for high-quality, randomized controlled trials to fully understand the potential benefits and risks of cannabinoids in cancer pain management.
Cannabinoids and opioid consumption in cancer pain: a systematic review and meta-analysis · 2026 · DOIConducting randomized controlled trials (RCTs) and implementation studies to substantiate clinical benefits and cost-effectiveness - Integrating edge-AI devices to enhance data privacy while providing low-latency assistance - Developing AI-augmented simulation and training curricula to promote rapid skill acquisition
Emerging technologies in interventional pain management: a scoping review on current innovations and future directions · 2026 · DOIThe clinical roles and evidence base of emerging technologies in interventional pain management remain unclear - There is a need for further research to substantiate clinical benefits and cost-effectiveness - The review identifies gaps for future research and guides future directions
Emerging technologies in interventional pain management: a scoping review on current innovations and future directions · 2026 · DOIPatient-related barriers, such as fear of addiction and limited knowledge, interfere with effective pain management. Clinical silence, or the relational failure of care, contributes to inadequate cancer pain management. The current approach to cancer pain management is inadequate, focusing primarily on pharmacological availability.
The unheard pain: why patient-related barriers remain the weakest link in cancer pain management · 2026 · DOI
Most-cited papers in Pain Management and Opioid Use
- MEASUREMENT OF PAIN · The Lancet · 1974 · 3,465 citations
- Persistent postsurgical pain: risk factors and prevention · The Lancet · 2006 · 3,383 citations
- Depression and Pain Comorbidity · Archives of Internal Medicine · 2003 · 2,921 citations
- Chronic pain: an update on burden, best practices, and new advances · The Lancet · 2021 · 2,233 citations
- Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults — United States, 2016 · MMWR Morbidity and Mortality Weekly Report · 2018 · 2,197 citations
- Pain and Its Treatment in Outpatients with Metastatic Cancer · New England Journal of Medicine · 1994 · 1,619 citations
- Pain demands attention: A cognitive–affective model of the interruptive function of pain. · Psychological Bulletin · 1999 · 1,376 citations
- Persistent Pain and Well-being · JAMA · 1998 · 1,113 citations
- Clinical Significance of Reported Changes in Pain Severity☆☆☆★ · Annals of Emergency Medicine · 1996 · 919 citations
- Management of Pain in Elderly Patients With Cancer · JAMA · 1998 · 914 citations
Most recent work
- Optimizing Opioid Use in Pain Management: A Comprehensive Review of Clinical Benefits, Risks, and Dependence · Healthcare · 2026
- LLM-driven collaborative framework for knowledge-enhanced cancer pain assessment and management · npj Digital Medicine · 2026
- Emergency clinicians’ knowledge and practice of pain assessment for older adults with cognitive impairment: A cross-sectional study · Australasian Emergency Care · 2026
- Double Jeopardy: Risks of Opioid–Benzodiazepine Co-prescription in Older Adults with Gastrointestinal Cancer · Annals of Surgical Oncology · 2026
- From relational measures to communicative mechanisms in chronic pain care · Journal of Psychosomatic Research · 2026
- Nonpharmacologic Approaches for Pain Management in Patients With Cancer Treated With Radiation Therapy · Seminars in Radiation Oncology · 2026
- A Qualitative Analysis of Multi-level Influences on Chronic Pain among Spanish-speaking Older Latino Adults in a Community Clinic in the United States · Journal of Cross-Cultural Gerontology · 2026
- The Use of Medical Marijuana Versus Opiates in Chronic Non-Cancer Pain · International Journal of Humanities and Social Science · 2026
- Topical Opioids for Pain in Malignant and Non-Malignant Chronic Ulcers: A Systematic Review · Spartan Medical Research Journal · 2026
- A patient-informed framework for Complex Regional Pain Syndrome care delivery: a mixed-methods study · Disability and Rehabilitation · 2026
Find a gap in your own Pain Management and Opioid Use sub-topic
This page shows what the Pain Management and Opioid Use literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →